New Key Statistics Module, Z-Score and F-Score
NAS:BCYC Key Ratios
| Market Cap $ M | 1,615.68 |
| Enterprise Value $ M | 802.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.95 |
| Price/Sales | 29.13 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 36.00 |
| EPS (TTM) $ | -3.29 |
| Beneish M-Score | -0.44 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.80 |
| EV-to-EBITDA | -5.02 |
| PEG | -- |
| Shares Outstanding M | 69.05 |
| Net Margin (%) | -450.64 |
| Operating Margin % | -532.50 |
| Pre-tax Margin (%) | -459.75 |
| Quick Ratio | 17.13 |
| Current Ratio | 17.13 |
| ROA % (ttm) | -21.68 |
| ROE % (ttm) | -29.19 |
| ROIC % (ttm) | -253.28 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.79 |
BCYC Number of Guru Trades
BCYC Volume of Guru Trades
Gurus Latest Trades with NAS:BCYC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BCYC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bicycle Therapeutics PLC Insider Transactions
No Available Data
News about NAS:BCYC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers